Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01932476 · ClinicalTrials.gov registry record · NA

Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes

A NA study, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT01932476 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01932476, a NA study, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the immune response causing celiac disease is related to the autoimmune response causing type-1 diabetes.

Interventions

  • DIETARY_SUPPLEMENT Gluten Challenge
  • DIETARY_SUPPLEMENT Sham Challenge

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2013-08
Est. Completion 2014-12
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT01932476

The ClinicalTrials.gov registry entry for NCT01932476 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Gluten Challenge is the first listed.

NCT01932476 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01932476 about?

NCT01932476 is a clinical study titled "Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes". The purpose of this study is to determine whether the immune response causing celiac disease is related to the autoimmune response causing type-1 diabetes.

What is the current status of trial NCT01932476?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2013-08. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01932476?

The interventions under investigation include: Gluten Challenge (DIETARY_SUPPLEMENT), Sham Challenge (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01932476?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.